NRX Pharmaceuticals Inc Ordinary Shares NRXP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NRXP is a good fit for your portfolio.
News
-
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
-
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
-
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
-
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
-
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
-
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
Trading Information
- Previous Close Price
- $3.02
- Day Range
- $3.00–3.25
- 52-Week Range
- $2.21–12.00
- Bid/Ask
- $3.03 / $3.10
- Market Cap
- $29.09 Mil
- Volume/Avg
- 233,600 / 227,026
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://nrxpharma.com
Valuation
Metric
|
NRXP
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
NRXP
|
---|---|
Quick Ratio | 0.24 |
Current Ratio | 0.36 |
Interest Coverage | −254.37 |
Quick Ratio
NRXP
Profitability
Metric
|
NRXP
|
---|---|
Return on Assets (Normalized) | −154.14% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −334.73% |
Return on Assets
NRXP
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Gwjzqqpr | Fhrhr | $550.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Stppmhjrk | Vvyzhc | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jwczzmsc | Rsnyxr | $98.1 Bil | |
MRNA
| Moderna Inc | Qntbsgvq | Kzmfp | $39.1 Bil | |
ARGX
| argenx SE ADR | Xthvxfdnn | Qmm | $21.7 Bil | |
BNTX
| BioNTech SE ADR | Kclcgkx | Ltqj | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zvqdmqc | Qrjtkw | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Fcqbzvdt | Lmdrphv | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vfmnpprwd | Gscgrvl | $12.5 Bil | |
INCY
| Incyte Corp | Fcnbpzkxc | Pchjzby | $11.9 Bil |